Translational medicine institute
Colorado State University (CSU) began construction of the C. Wayne McIlwraith Translational Medicine Institute (TMI) in June 2017.
The institute is being constructed at CSU’s south campus between the Diagnostic Medicine Centre and the Orthopaedic Research Centre.
The facility is expected support new discoveries in translational medicine for humans and animals, enhancing CSU’s research expertise in areas such as orthopaedics, biomedical engineering, immunology, infectious disease and surgical advances.
The building is named after Dr Wayne McIlwraith, a veterinarian and professor of CSU, as well as founding director of CSU’s Orthopaedic Research Centre.
Built at a cost of $65m, the facility is expected to be completed by late-2018.
The translational medicine institute will have a total space of 116,194ft², with 48,550ft² dedicated to animal care facilities.
The institute will contain three animal holding buildings, a research horse barn and a sheep barn, as well as a lab facility for smaller animals. It will also accommodate CSU’s College of Veterinary Medicine and Biomedical Sciences.
Sophisticated facilities will be available for research and education in the field of stem cells, engineered tissues and regenerative and biological therapies.
The institute will offer space for educators and innovators from academia, industry and public agencies to collaborate and pursue the development of promising medical technologies. It will also be equipped with research spaces, clinical resources, and conference areas.
In addition, the facility will enhance entrepreneurial models and optimise innovation timelines.
Replacing facilities currently present at the construction site is expected to be completed at a cost of $19.8m.
The topping out ceremony of the TMI building was held in November 2017.
Clark Enersen Partners was contracted to provide architecture, interior design, master planning and landscape architecture services, as well as and civil, mechanical, electrical and structural engineering for the TMI building.
Tetrad Property Group (TPG) is providing planning, designing, and financing services, as well as project management and operations and maintenance (O&M) activities for the project under a public-private partnership (P3).
Once construction is completed, TPG will also carry out general building maintenance and operations for a period of 30 years.
The construction contract was awarded to JE Dunn Construction.
John and Leslie Malone contributed $42.5m to the project, including $32.5m for construction and $10m for operations, while Princess Abigail Kawananakoa provided $20m.
Additional expenses for the project will be paid for by the State of Colorado and CSU.
Thermo Fisher Scientific (Thermo Fisher) will establish a new pharmaceutical services facility for integrated biologics and sterile drug development and…
Lykan Bioscience opened a purpose-built SMART Manufacturing™ facility for developing cell-based therapies in Hopkinton, Massachusetts, US, in September 2020. The…
Merck announced the expansion of its high-potent active pharmaceutical ingredient (HPAPI) and antibody-drug conjugate (ADC) production capabilities and capacity at…